IBD Highlights
The use of biosimilars in pediatric inflammatory bowel disease: a nation-wide survey
Valeria Dipasquale, Claudio Romano
11Unità Operativa di Gastroenterologia Pediatrica e Fibrosi Cistica Dipartimento di Patologia Umana Dell’Adulto e Dell’Età Evolutiva “G. Barresi” Università degli Studi di Messina
The use of biosimilars in pediatric inflammatory bowel disease (IBD) has recently increased. The knowhow of these drugs is still limited in the pediatric experience. Twenty-six pediatric IBD Units in Italy responded to a web survey covering the most relevant aspects of biosimilars in pediatric IBD, including advantages, disadvantages, costs and traceability. The aim was to assess current awareness and real-life use of biosimilars in pediatric IBD in Italy